The Sound of Silence

One thing is sure, a great change of our psychological attitude is imminent, that is certain… because we need more… we need more psychology, we need more understanding of human nature because the only real danger that exists is man himself, he is the great danger, and we are pitifully unaware of it. We know nothing of man, far too little. His psyche should be studied because we are the origin of all coming evil. — Carl Gustav Jung

Monday, February 28, 2022

Worst Fears Realized: Pfizer mRNA Transcribes into DNA

https://igorchudov.substack.com/p/worst-fears-realized-pfizer-mrna/comment/5264366?utm_source=url
Rob at 9:39 PM No comments:

CIMB | Free Full-Text | Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line

https://www.mdpi.com/1467-3045/44/3/73
Rob at 2:28 PM No comments:

Thursday, February 24, 2022

Pfizer Company Suppressed Ivermectin Use As COVID Treatment – By Mordechai Sones – 1 Aug 2021 | xenagoguevicene

https://xenagoguevicene.wordpress.com/2021/08/04/pfizer-company-suppressed-ivermectin-use-as-covid-treatment-by-mordechai-sones-1-aug-2021/
Rob at 8:37 PM No comments:

Friday, February 18, 2022

High Oxalate: A Major Factor in Tissue and Blood Vessel Health — Great Plains Laboratory

https://www.greatplainslaboratory.com/gpl-blog-source/2022/high-oxalate-a-major-factor-in-tissue-and-blood-vessel-health
Rob at 11:49 PM No comments:

Insight: The Dirty Secrets Behind Covid-19 – Biblicism Institute

https://biblicisminstitute.wordpress.com/2020/03/07/the-dirty-secrets-behind-covid-19/
Rob at 8:06 PM No comments:

They Got Caught

Rob at 3:42 PM No comments:

Monday, February 7, 2022

Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial | The BMJ

https://www.bmj.com/content/375/bmj.n2635
Rob at 8:51 PM No comments:

Stories – Fenbendazole resource

https://www.fenbendazole.org/stories/
Rob at 8:46 PM No comments:

Melatonin as an antioxidant: under promises but over delivers - PubMed

https://pubmed.ncbi.nlm.nih.gov/27500468/
Rob at 8:45 PM No comments:

Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis - PubMed

https://pubmed.ncbi.nlm.nih.gov/28420185/
Rob at 8:43 PM No comments:

Saturday, February 5, 2022

JRE Missing Joe Rogan Podcast Spotify removed episodes list

https://jremissing.com/
Rob at 4:09 PM No comments:

Friday, February 4, 2022

Ivermectin inactivates the kinase PAK1 and blocks the PAK1-dependent growth of human ovarian cancer and NF2 tumor cell lines - PubMed

https://pubmed.ncbi.nlm.nih.gov/22495656/
Rob at 2:04 PM No comments:

Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage - PubMed

https://pubmed.ncbi.nlm.nih.gov/28847725/
Rob at 2:04 PM No comments:

Ivermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathway - PMC

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8650430/
Rob at 2:04 PM No comments:

Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes - PMC

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7272521/
Rob at 2:03 PM No comments:

Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug - PubMed

https://pubmed.ncbi.nlm.nih.gov/32474842/
Rob at 2:03 PM No comments:

Ivermectin as an inhibitor of cancer stem‑like cells - PubMed

https://pubmed.ncbi.nlm.nih.gov/29257278/
Rob at 2:03 PM No comments:

Ivermectin has New Application in Inhibiting Colorectal Cancer Cell Growth - PubMed

https://pubmed.ncbi.nlm.nih.gov/34483925/
Rob at 2:03 PM No comments:

Ivermectin, a potential anticancer drug derived from an antiparasitic drug - PMC

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7505114/
Rob at 2:03 PM No comments:

The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug - PMC

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC5835698/
Rob at 1:38 PM No comments:
‹
›
Home
View web version

About Me

Rob
View my complete profile
Powered by Blogger.